carbostyril has been researched along with Myeloproliferative Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ågerstam, H; Billström, R; Dreimane, A; Landberg, N; Rissler, M | 1 |
| Ebihara, Y; Hanada, S; Imai, K; Konishi, C; Matsuzaka, E; Mochizuki, S; Nakauchi, H; Otsu, M; Takagi, H; Tsuji, K; Yamamoto, S | 1 |
| Cao, HQ; Li, F; Li, HQ; Mei, JG; Qiu, XH; Shao, JJ; Zhai, YP | 1 |
| Barosi, G; Rosti, V | 1 |
| Karp, JE; Lancet, JE | 1 |
| Elhamri, M; Thomas, X | 1 |
| Chase, A; Cross, NC; Grand, FH | 1 |
3 review(s) available for carbostyril and Myeloproliferative Disorders
| Article | Year |
|---|---|
Novel strategies for patients with chronic myeloproliferative disorders.
Topics: Chronic Disease; Humans; Interferon alpha-2; Interferon-alpha; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Quinolones; Recombinant Proteins; Thalidomide | 2009 |
Farnesyl transferase inhibitors in myeloid malignancies.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Enzyme Inhibitors; Farnesyltranstransferase; Hematologic Neoplasms; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myeloid, Acute; Models, Biological; Myeloproliferative Disorders; Piperazines; Pyrimidines; Quinolones; ras Proteins; Signal Transduction | 2003 |
[Farnesyltransferase inhibitors: preliminary results in acute myeloid leukemia].
Topics: Alkyl and Aryl Transferases; Benzodiazepines; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Imidazoles; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 1; Myeloproliferative Disorders; Piperidines; Protein Prenylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Quinolones; ras Proteins; rho GTP-Binding Proteins | 2005 |
4 other study(ies) available for carbostyril and Myeloproliferative Disorders
| Article | Year |
|---|---|
Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Topics: Benzimidazoles; Chromosomes, Human, Pair 8; Dasatinib; Humans; Imidazoles; Inhibitory Concentration 50; Male; Myeloproliferative Disorders; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcr; Pyridazines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Sequence Analysis, DNA; Translocation, Genetic; Tumor Cells, Cultured; Young Adult | 2017 |
Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
Topics: Adolescent; Benzimidazoles; Cells, Cultured; Drug Evaluation, Preclinical; Hematopoiesis; Humans; Imatinib Mesylate; Imidazoles; Induced Pluripotent Stem Cells; Male; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Pyridazines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Staurosporine; Translocation, Genetic | 2015 |
Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
Topics: Animals; Apoptosis; Benzamides; Benzimidazoles; Cell Line; Cell Proliferation; Gene Expression; Humans; Imidazoles; Myeloproliferative Disorders; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins; Pyrazoles; Pyridazines; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Translocation, Genetic | 2017 |
Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
Topics: Adult; Aged; Benzimidazoles; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromosomes, Human, Pair 8; DNA-Binding Proteins; Female; Humans; Male; Middle Aged; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcr; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Syndrome; Transcription Factors | 2007 |